Biologics Market Size to Reach USD 567.96 Billion in 2028 | Rising Demand for Biologics Contract Manufacturing Services by Biopharmaceutical Companies is a Significant Factor Driving Industry Demand, says Emergen Research

VANCOUVER, BC, March 3, 2022 /PRNewswire/ -- The global Biologics market size is expected to reach USD 567.96 Billion in 2028 and register a revenue CAGR of 8.4% over the forecast period, according to recent analysis by Emergen Research. Steady market revenue growth can be attributed to increasing number of strategic alliances between biopharmaceutical firms and Biologics contract manufacturing service providers. Large-molecule Biologics find wide application in lifesaving therapies and are witnessing considerably high demand due to rising focus on technological advancements. Several biopharmaceutical companies have Biologics products in the development pipeline that hold immense significance in the treatment of various diseases.

Get Free Sample PDF Copy of the Report@
https://www.emergenresearch.com/request-sample/61

However, Biologics-based therapies present various challenges with respect to commercialization of products at an affordable cost, along with maintaining highest quality standards. Scientific intricacies and sophisticated high-end technologies involved in large molecule development pose challenges in terms of high investments, extended timelines, very stringent regulatory compliance, and inspection. As a result, biopharmaceutical firms seek to partner with contract manufacturing organizations to meet current supply shortages, defer investments till the success of clinical trials, and balance risks associated with technology.

Rising focus by biopharma companies on Biologics drugs discovery and development, especially on antibody therapeutics, is a key factor driving market revenue growth. Antibody therapeutics is considered to be clinically effective for several disorders, such as immunology and oncology. The method provides enhanced target specificity and improvements on previously challenging targets, including g-coupled protein receptors and ion channels. Rise in numbers of antibody drug entities going to development pipeline is expected to drive implementation of antibody therapeutics, and in turn, support market revenue growth.

However, concerns associated with biological safety of biological therapeutics, particularly in the  geriatric population, may hinder market revenue growth to some extent over the forecast period. It has been found that biologic therapies in geriatric patients suffering from inflammatory diseases increases infection risk than in patients who were not given Biologics therapy.

Discount Available on Biologics market report [Click Here]@ https://www.emergenresearch.com/request-discount/61

Some Key Highlights From the Report

• In December 2020, WuXi Biologics entered into an agreement with Bayer for the acquisition of Bayer's Drug Substance (DS) production facility at Wuppertal site.
• Microbes constitute a significant proportion of hosts used in the production of recombinant pharmaceuticals for treating human beings, mostly owing to lack of unconventional post-translational modifications, poor solubility, proteolytic instability, and cell stress responses trigger.
• Rising demand for biosimilars to increase patient access to Biologics, improve efficiency, increase cost savings by healthcare facilities, and offer a large number of treatment options is driving revenue growth of the global Biologics market. Biosimilars increase the use of therapies associated with Biologics, resulting in an overall improvement in health outcomes.
• Biologics therapy is used for coronary plaque reduction in the treatment of cardiovascular diseases. Also, Biologics is considered beneficial in treatment of psoriasis and other inflammatory ailments.
• Biologics market in North American accounted for largest revenue share in 2020, owing to rising prevalence of chronic diseases, presence of leading biopharmaceutical firms, and a rise in the number of biotech firms entering the market in countries in the region.
• Major companies operating in the global Biologics market include Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung Biologics, Merck & Co. Inc., Celltrion, AbbVie Inc., Johnson & Johnson Services Inc., Eli Lilly & Company, F Hoffman La Roche, Addgene, Novartis AG, and GlaxoSmithKline.
• Emergence of several startups such as ILYA Pharma, Elasmogen, Cygnal Therapeutics, TiumBio, and Entos Pharmaceuticals is contributing significantly to market growth.

Explore Complete Report Description and Table of Contents of Biologics Market Report@ https://www.emergenresearch.com/industry-report/Biologics-market

Emergen Research has segmented the global Biologics on the basis of source, product type, application, and region:

• Source Outlook (Revenue, USD Billion; 2018-2028)
• Microbial
• Mammalian
• Others
• Product Type Outlook (Revenue, USD Billion; 2018-2028)
• Monoclonal Antibodies
• Vaccines
• Recombinant Hormones/Proteins
• Cellular-Based Biologics
• Gene-Based Biologics
• Others
• Application Outlook (Revenue, USD Billion; 2018-2028)
• Cancer
• Infectious Diseases
• Immunological Diseases
• Cardiovascular Diseases
• Hematological Disorders
• Others

Customization Available as per your Specific Requirement@ https://www.emergenresearch.com/request-for-customization/61

• Regional Outlook (Revenue, USD Billion; 2018–2028)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Turkey
• Rest of MEA

Latest Blog Articles Published by Emergen Research:

Bioreactors Market, By Material Type (Glass, Single-Use, Stainless Steel), By Range (5L-20L, 20L-200L, 200L-1500L, Above 1500L), By Control Type (Manual, Automated), By Suppliers, By Production Scale, By End-Use, and By Region Forecast to 2030.

Biobanking Market Size, Share, Trends, By Product & Services (Equipment, Consumables, Services, Software), By Sample Type (Biological Fluids, Human Tissues, Blood Products), By Storage Type, By Application, and By Region Forecast to 2030.

Cryotherapy Market By Product (Localized Cryotherapy Devices, Cryosurgery Devices, Cryochambers & Cryosaunas, Gas Cylinders, Others), By Therapy (Icepack Therapy, Cryosurgery, Chamber Therapy), By Application, By End-Use, and By Region Forecast to 2028.

Biodefense Market Size, Share, Trends, By Product Type (COVID-19 Vaccine, Anthrax Vaccine, Others), By Biothreat Detection Device Type, By End-Use, and By Region Forecast to 2028.

Augmented Reality and Virtual Reality in Healthcare Market By Technology (Augmented Reality, Virtual Reality), By Component (Hardware, Software, Services), By Application (Surgery, Training & Education), By End-use (Hospitals, Clinics), and By Region Forecast to 2030.

Telehealth Market, By Type (Tele-Home and Tele-Hospital), By Component, By Deployment Model (Web & Cloud-based and On-premises), By Application, By End-user, and By Region Forecast to 2028

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: Market Research Company 
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com 
Visit for More Insights: https://www.emergenresearch.com/insights 
Explore Our Custom Intelligence services | Growth Consulting Services

Read our Press Release on Biologics @ https://www.emergenresearch.com/press-release/global-Biologics-market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg